EMAIL THIS PAGE TO A FRIEND

Gut

Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice.


PMID 25416068

Abstract

Fibroblast growth factors (Fgfs) are key orchestrators of development, and a role of Fgfs in tissue repair is emerging. Here we studied the consequences of inducible loss of Fgf receptor (Fgfr) 4, the major Fgf receptor (Fgfr) on hepatocytes, alone or in combination with Fgfr1 and Fgfr2, for liver regeneration after PH. We used siRNA delivered via nanoparticles combined with liver-specific gene knockout to study Fgfr function in liver regeneration. Liver or blood samples were analysed using histology, immunohistochemistry,real-time RT-PCR, western blotting and ELISA. siRNA-mediated knockdown of Fgfr4 severely affected liver regeneration due to impairment of hepatocyte proliferation combined with liver necrosis.Mechanistically, the proliferation defect resulted from inhibition of an Fgf15-Fgfr4-Stat3 signalling pathway,which is required for injury-induced expression of the Foxm1 transcription factor and subsequent cell cycle progression, while elevated levels of intrahepatic toxicbile acids were identified as the likely cause of the necrotic damage. Failure of liver mass restoration in Fgfr4 knockdown mice was prevented at least in part by compensatory hypertrophy of hepatocytes. Most importantly, our data revealed partially redundant functions of Fgf receptors in the liver, since knock down of Fgfr4 in mice lacking Fgfr1 and Fgfr2 in hepatocytes caused liver failure after PH due to severe liver necrosis and a defect in regeneration. These results demonstrate that Fgfr signalling in hepatocytes is essential for liver regeneration and suggest activation of Fgfr signalling asa promising approach for the improvement of the liver's regenerative capacity.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1300019
Anti-FGFR4 (N-term) antibody produced in rabbit, IgG fraction of antiserum, buffered aqueous solution
SAB1300886
Anti-FGFR4 antibody produced in rabbit, saturated ammonium sulfate (SAS) precipitated, buffered aqueous solution
HPA027273
Anti-FGFR4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab1
HPA027369
Anti-FGFR4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab2
HPA028251
Anti-FGFR4 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, ab3
SAB4300637
Anti-FGFR4 antibody produced in rabbit, affinity isolated antibody
EHU085491 MISSION® esiRNA, esiRNA human FGFR4 (esiRNA1)
EMU013351 MISSION® esiRNA, esiRNA targeting mouse Fgfr4 (esiRNA1)
SAB1300137
Monoclonal Anti-FGFR4 antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
SAB5300467 Monoclonal Anti-FGFR4 antibody produced in mouse, clone 4H2B10B2, ascites fluid
SAB5300468
Monoclonal Anti-FGFR4 antibody produced in mouse, clone 7H1, ascites fluid
SAB1402195
Monoclonal Anti-FGFR4 antibody produced in mouse, clone 1E2, purified immunoglobulin, buffered aqueous solution